• Revance Gears Up for Launch of RT002 Neurotoxin

    27 days ago - By Surgical Aesthetics Magazine

    Revance Therapeutics has established four new positions at the company as it prepares for the launch and commercialization of its daxibotulinumtoxinA injectable for the treatment of glabellar lines.
    Dustin Sjuts has been appointed vice president of strategy and sales, aesthetic and therapeutic; Ben Putman is vice president of digital; and Marc Korenberg is senior director of commercial operations. In addition, Erica Bazerkanian has been promoted to vice president of marketing, aesthetics and therapeutics. All four will report to Todd Zavodnick, chief commercial officer and president of...
    Read more ...